Publications for Hariette Rosen Mogul harriette_mogul@nymc.edu

NYMC School of Medicine
  • Mogul, H., Freeman, R., & Nguyen, K. (2016). Metformin-sustained weight loss and reduced android fat tissue at 12 months in  EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance): A double blind, placebo-controlled, randomized trial of normoglycemic women with midlife weight gain. Endocrine Practice, 22(5), 575-586. doi:10.4158/EP151087.OR

  • Mogul, H. R., Freeman, R., Nguyen, K., Frey, M., Klein, L. A., Jozak, S., & Tanenbaum, K. (2014). Carbohydrate modified diet & insulin sensitizers reduce body weight & modulate metabolic syndrome measures in EMPOWIR (Enhance the Metabolic Profile of Women with Insulin Resistance): A randomized trial of normoglycemic women with midlife weight gain. PLoS One, 9(9), e108264. doi:10.1371/journal.pone.0108264

  • Deal, C. L., Tony, M., Hoÿbye, C., Allen, D. B., Tauber, M., Christiansen, J. S., . . . Mogul, H. R. (2013). Growth Hormone Research Society Workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism, 98(6), E1072-E1087. doi:10.1210/jc.2012-3888